Combination and sequential therapy for the treatment of Osteoporosis [electronic resource] / Felicia Cosman.
Material type:
FilmSeries: Henry Stewart talksBiomedical & life sciences collection. Bone in health and disease: Publisher: London : Henry Stewart Talks, 2015Description: 1 online resource (1 streaming video file (22 min.) : color, sound)Subject(s): Chemotherapy, Combination | Osteoporosis -- Chemotherapy | Osteoporosis -- Treatment | Antibodies, Monoclonal, Humanized -- therapeutic use | Bone Density Conservation Agents -- therapeutic use | Bone Density | Diphosphonates -- therapeutic use | Drug Therapy, Combination | Osteoporosis -- drug therapy | Raloxifene -- therapeutic use | Teriparatide -- therapeutic useOnline resources: Click here to access online | Series Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Current pharmacologic management of osteoporosis -- Choosing anabolic vs. antiresorptive therapy -- The PaTH trial -- Response to teriparatide (TPTD) -- Evaluating combination and sequential therapy -- Zoledronic acid and daily TPTD study -- DATA trial (TPTD or denosumab monotherapy vs. combination) -- TPTD in naïve vs. treatment experienced women -- TPTD monotherapy vs. combination therapy -- TPTD after prior treatment (bisphosphonate, raloxifene or alendronate) -- Total hip BMD percent changes -- Switch to TPTD in patients on prior denosumab or antiresorptive treatment -- TPTD in treatment experienced (switch vs. add) -- Hip & spine strength and volumetric BMD -- CONFORS trial -- Bone turnover.
Access restricted to subscribers.
Mode of access: World Wide Web.